BRIEF-Sarepta Therapeutics Posts Q4 Loss Per Share Of $2.40
BRIEF-Sarepta Therapeutics Posts Q4 Loss Per Share Of $2.40
* SAREPTA THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2020 FINANCIAL RESULTS AND RECENT CORPORATE DEVELOPMENTS
* Q4 NON-GAAP LOSS PER SHARE $1.84
* Q4 EARNINGS PER SHARE ESTIMATE $-1.87 -- REFINITIV IBES DATA
* NET PRODUCT SALES FOR Q4 OF $122.6 MILLION
* QTRLY TOTAL REVENUES $145.1 MILLION VERSUS $100.1 MILLION
* QTRLY LOSS PER SHARE $2.40
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
March 1 (Reuters) - Sarepta Therapeutics Inc :
* SAREPTA THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2020 FINANCIAL RESULTS AND RECENT CORPORATE DEVELOPMENTS
* Q4 NON-GAAP LOSS PER SHARE $1.84
* Q4 EARNINGS PER SHARE ESTIMATE $-1.87 -- REFINITIV IBES DATA
* NET PRODUCT SALES FOR Q4 OF $122.6 MILLION
* QTRLY TOTAL REVENUES $145.1 MILLION VERSUS $100.1 MILLION
* QTRLY LOSS PER SHARE $2.40
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
路透3月1日電-Sarepta治療公司：*Sarepta治療公司宣佈2020年第四季度和全年的財務業績和最近的公司發展*第四季度非GAAP每股虧損1.84美元*第四季度每股收益預估-1.87美元-REFINITIV IBES數據*第四季度產品淨銷售額為1.226億美元*qtrly總收入為1.451億美元，而不是1.01億美元*Qtrly每股虧損2.40美元Eikon的源文本：進一步的公司報道：(Reurs.Briefs@thomsonreurs.com；)
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧